Cardiology

EMJ had the pleasure of interviewing Alexander E Berezin, Fellow of the European Society of Cardiology (ESC) on his research in cardiology…

This plenary session began with a focus on cutting edge research into the role of the immune system in atherosclerotic cardiovascular dise…

Implantable cardioverter defibrillators (ICDs), pacemakers, and cardiac resynchronisation therapy (CRT) devices are placed in a pocket…

This article will focus on how the emerging field of digital health technology can aid screening for heart disease and explore its usefulness in disease specific and population specific groups.

Worldwide, tobacco use causes more than 7 million deaths every year, a death toll that could increase to 8 million by the end of the…

Heart failure is a complex clinical syndrome, which can substantially impair quality of life and increase mortality risk. With the appropriate care, this condition is now both preventable and treatable for many patients. This infographic provides an overview of several key messages from the 2021 European Society of Cardiology (ESC) guidelines for medical management of heart failure.

Cardiac myosin inhibitors (CMI) are the first medications specifically targeting the underlying pathophysiology of hypertrophic cardiomyopathy